Cell Signaling Technology

17-AAG

#8132 · $316

100
Citing papers
7.6k
Combined citations
Supplier page Find this product

Research areas

HER2/EGFR in Cancer Research17Monoclonal and Polyclonal Antibodies Research12Cell death mechanisms and regulation10interferon and immune responses7Cytokine Signaling Pathways and Interactions7Melanoma and MAPK Pathways6Glycosylation and Glycoproteins Research6Protein Kinase Regulation and GTPase Signaling6

Papers citing this product

1
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Cell·2010·1.5k cit.·DOI
2
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Journal of Biological Chemistry·2005·756 cit.·DOI
3
Suppression of cell growth and invasion by miR-205 in breast cancer
Cell Research·2009·363 cit.·DOI
4
Signaling via ErbB2 and ErbB3 Associates with Resistance and <i>Epidermal Growth Factor Receptor</i> (<i>EGFR</i>) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells
Clinical Cancer Research·2006·265 cit.·DOI
5
Multidimensional chemical control of CRISPR–Cas9
Nature Chemical Biology·2016·188 cit.·DOI
6
Measles virus V protein blocks interferon (IFN)‐α/β but not IFN‐γ signaling by inhibiting STAT1 and STAT2 phosphorylation
FEBS Letters·2003·188 cit.·DOI
7
HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
Molecular Cancer Therapeutics·2008·126 cit.·DOI
8
Loss of 5-methylcytosine alters the biogenesis of vault-derived small RNAs to coordinate epidermal differentiation
Nature Communications·2019·124 cit.·DOI
9
Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo
Chemical Science·2015·121 cit.·DOI
10
Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification
British Journal of Cancer·2011·120 cit.·DOI
17-AAG — Evidence — PubIndex